Shaw and Partners acted as Lead Manager to the capital raising by Apiam Animal Health News19 Apr 2021

Shaw and Partners was pleased to be appointed as Lead Manager to the capital raising by Apiam Animal Health.

 

The company successfully completed an Institutional Placement of 7.5 million fully paid shares at 80 cents per share, raising a total of $6.0 million.

 

Pricing for the Placement was determined via an institutional bookbuild with the Placement price of 80 cents representing a 5.9% discount to the last traded price of Apiam’s shares on 14th April 2021, and a 5.6% discount to the 10-day volume weighted average price of the Company’s shares.

 

The Placement saw strong support from institutional investors, improving the institutional representation on Apiam’s register. Funds raised will be used to accelerate the Company’s regional expansion plans, through investment in opening new greenfield clinics as well as strategic acquisitions, in accordance with Apiam’s ongoing acquisition program.

 

Dr Chris Richards, Managing Director of Apiam said “The rapid growth in pet and production animal ownership in regional corridors, particularly as a result of changing population demographics and favourable seasonal conditions, has presented a very exciting market opportunity for Apiam.”

 

“This placement will support us in accelerating our regional expansion plans and capturing the significant growth we are seeing in many veterinary areas. As an established regional player, Apiam is well placed to scale-up and leverage these opportunities as they emerge.”

 

The offer was available to Australian Sophisticated and Professional Investors only.

 

For more information please contact your Shaw and Partners Adviser.

 

About Apiam Animal Health Limited

Apiam Animal Health is positioned in the Australian market as a vertically integrated animal health business providing a range of products and services to Production and Mixed animals. Apiam Animal Health’s strategy is to service Production and Mixed animals throughout their lifecycle, including the provision of veterinary services, ancillary services, genetics, wholesale and retail of related products, together with technical services related to food-chain security.

Related Articles
News02 Oct 2025 Shaw and Partners SMA platform surpasses $3 billion in Funds Under Management
Shaw and Partners is proud to announce that its Separately Managed Account (SMA) platform has now surpassed $3 billion in Funds Under Management (FUM). Over the past twelve months ... Read More
News01 Oct 2025 Shaw and Partners expands in New Zealand with JMI Wealth rebrand
Shaw and Partners is proud to announce a significant milestone in our trans-Tasman growth journey. Effective today, JMI Wealth, part of Investment Services Group (ISG), officially ... Read More
News19 Sep 2025 Shaw and Partners appoints four advisers from Kennedy Partners Wealth
Shaw and Partners is pleased to announce the appointment of four highly regarded advisers — Evelyn Vertzagias, Tim Bowers, Peter Webster and Patrick Anwandter — who have joined our... Read More
News21 Aug 2025 Shaw and Partners appointed as a Joint Lead Manager to Revolution Private Credit Income Trust initial public offering
Shaw and Partners is pleased to have been appointed as a Joint Lead Manager to Revolution Private Credit Income Trust (ASX:REV) $400m initial public offering. Revolution Private C... Read More
A - Z  % Change  
{{data.Symbol}} {{data.CompanyName}} {{data.Close}} {{data.AsAt | date :'shortTime'}} {{data.Movement | number : 2}} {{data.MovementPercent | number: 2}}%